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In Inany inflaInInatory derInatoses leukocyte func-
tion-associated antigen-lIintercellular adhesion Inol-
ecule-1 Inediated T -cell/keratinocyte adhesion is 
considered to play an iInportant role. Pentoxifylline 
(PTX), a Inethylxanthine derivative widely used for 
the syInptoInatic treatInent of various vascular disor-
ders, was recently found to have anti-inflaInInatory 
effects . PTX can suppress tUInor necrosis factor-a 
production and function, and inhibits leukocyte-en-
dothelial cell adherence. The aiIn of the present study 
was to investigate whether PTX also interferes with 
T -cell/keratinocyte binding. Peripheral blood T cells 
were activated with phorbol Inyristate acetate and 
co-incubated with interferon-y- or tUInor necrosis 
factor-a-stiInulated keratinocytes (SVK 14 cells) in 
the presence or absence of PTX. Using an enzyIne-
linked iInInuno cell adhesion assay PTX was found to 
inhibit T -cellikeratinocyte adhesion in a dose-depen-
dent Inanner. A siInilar inhibition was found when 
PTX was replaced by isobutylInethylxanthine, an-
other Inethylxanthine derivative, or by a cOInbina-
P entoxifYlline (PTX) , a m ethylxanthin e derivative, was initially characterized as an agent, which enhances red blood cell defonnability and decreases blood viscosity by inhibition of platelet aggregation. Therefore, it has been used for the symptomatic treatment of various 
vascular disorders, including intermittent claudication, ischemic leg 
ulcers, and hyperviscosity associated with polycythemia and multi-
ple myeloma [1]. Favorable resu lts of PTX have also been reported 
in severa] skin disorders, such as necrobiosis lipoidica [2], cutan eous 
polyarteritis nodosa [3], and generalized morphea [4]. In addition, 
PTX has been shown to prevent recurrent furunculosis [5] and to 
suppress irritant and contact hypersensitivity reactions [6,7]. T hese 
latter observations suggest that PTX, apart from its effects on red 
blood cells and blood viscosity, may also have significant anti-
inflammatory effects. The mechanisms by which PTX exerts its 
beneficial effect in these conditi ons is no t com plete ly understood. 
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cion of two cyclic adenosine Inonophosphate ana-
logues. No Inajor effect on T-celllkeratinocyte 
adherence was observed when PTX was present dur-
iog the pre-incubation of keratinocyte Inonolayers 
with tUInor necrosis factor-a or interferon-l' prior to 
che adhesion assay. In keratinocyte Inonolayers the 
ioterferon-l' or tUInor necrosis factor-a induced in-
tercellular adhesion Inolecule-1 expression could not 
be inhibited by PTX. However, when PTX was added 
to short-terIn organ cultures of norInal hUInan skin 
biopsies, the lipopolysaccharide- and tUInor necrosis 
f~ctor-a-induced keratinocyte intercellular adhesion 
J:J'.0Iecule-1 expression was blocked cOInplete ly. The 
i.tJ.terferon-y-induced ICAM-1 expression was not 
blocked by PTX. The results presented herein sug-
gest that iInpaired T -cell/keratinocyte binding Inay 
be one of the InechanisIns by which PTX exerts a 
beneficial effect in certain inflaInInatory derInatoses. 
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Most studies to date have focused on the effect of PTX on tumor 
r)ecrosis factor (TNF)-a production and fun ction. PTX has been 
found to suppress the production ofTNF-a by murine and human 
£P3crophages, both at the mRNA and protein level [8,9] , to block 
th.e activation of polymorphonuclea r leukocytes by lipopolysacch a-
rides (LPS) , TNF-a, and interleukin (IL)-l [10] , and to prevent 
septic shock in laboratory animals, which is also m ediated by 
'):'I'JF-a [11] . In addition, PTX ca n block phytohem agglutinin-
ip duced IL-2 receptor expression by lymphocytes [1 2], and inhibits 
adh esion of monocytes, granulocytes , and T cell s to endothelium * 
[13]. 
T hese observations prompted us to investiga te whether PTX can 
also interfere with adh erence of T cells to keratinocytes. T celli 
~e;ratinocyte binding is mediated by the adhesion m olecules leuko-
cyte fun ction-associated antigcn- l (T cells) and intercellular adhe-
s:ion molecule-l (JCAM-l) (keratinocytes), and is considered to 
I'1~y an important role in various inflammatory disorders. 
M ATERIAL AND METHODS 
CJ:temicals and Monoclonal Antibodies PTX, 10- 5-10- 2 M (Sigma 
C I'lemical Co ., St. Louis, MO) ; phorbol myristate acetate (PMA), 0.1, 0.5 
aJ1d 5 ng/ml (Sigma); in te rferon-gamma (IFN-y) , 300 U/ml Oanssen 
* Weiss JM, Simon J C, Vestweber D, W eyl A, Peschen M , Schopf E, 
V~scheidt W: Pentoxifylline inhibits T-cell adhes ion to endothelial ceUs 
(~I?str). A rc" Den"ato( R es 186:159, 1994. 
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Biochcmica Belgium); T NF-a, 1000 U / ml (Gcnzyme, Cambridge, MA); 
isobutylmethylxan thill e (IJ3MX) , 10- 3 M (Aldrich C hemie, Brussels, Bel-
gium); cyclic adenos ine monophosphate (cAM P) analogues (dibutyryl 
cAMP and 8-bromo cAMP) , 10- 3 M (S igma), lipopo lysaccharidc (LPS) , 50 
J.Lg/m l (Difco Laboratories, Detroit. M I) ; Wehi-C AM-1 (anti-ICAM-l, 
C054, IgG1, a kind gift from Dr. A. W. Boyd, Melbourne, Austra li a); 'lnd 
CLB-T200 (anti- leukocyte commOIl antigen, C045, 19G1, Central Labo-
ratory ofthc Netherlands [~ed C ross Blood T ransfusion Service) were used. 
T Lymphocytes and Keratinocytes 
T LYlllphocyles: Human peripheral blood mononuclear leukocytes [:;'om 
hea lthy vo lun tee rs wcre o btained by centrifugatioll of defibrinized venOllS 
b lood over a Fico ll-Paque density grad ient (Pharmacia , Uppsala , Sweden). 
T he in terface cell s were co llec ted and washed with RPMI-1640 (Gib co 
BRL, Gaithersburg, MO) , supplemented with 10% heat-inactivated fQta l 
bovine serum (Hyclone Laboratories , Logan, UT). T he cells were dep leted 
of B lymphocytes alld monocytes by fil tration over Ilylonwool (99'Vt. T 
lymphocytes) and resuspellded in I~PM I-1640 with l O% fe tal bovine serum 
at a concen tratioll of 2 X 106 cells/ml. 
Kernli"ocyte Cell Li"e: T he Simian virus 40-transformed human keratil:to-
cyte ce ll line SVK14 was cultured (37°C, 5% CO2 ) in O ulbecco's modi fied 
Eagle's medium (OMEM) and Ham's F1 2 medi um (3 :1) , supplemented 
w ith 10% feta l bovine se rum , hydrocortisone (S igma , 0.4 J.Lg/ ml) , L-
glu tamille (2 mM) , penicillin (100 U/ ml) , and streptomycin (100 J.Lgitn l, 
Gibco BRL) . T he keratinocytcs were induced to express ICAM-l by 
pretrea tment with IFN-y or TNF-a du ring 48 h. 
Norlllal I-fr",ta" Kernli""cyle>: Suspellsions of single keratinocytes Were 
o btained fro m human fo reskin . T he up per derma l and epidermal part of t h e 
foreskin , cleared of fibrou s ti ssue and r.,t, was stre tched on a sterile filter 
paper in a petri di sh with thermolysill (0.5 mg/ ml , Sigma) and incuba ted 
overnight at 4°C . T he epidermis was gently stripped £i'om the den \,is, 
co llected in a tube with 0 .025% trypsin (Gibco BRL) , and incubated fo r 10 
min at 37°C. T he ce ll suspens ion was filtered th ro ugh nylon gauze . Cells 
were seeded in collagen-coated (Vitrogen 100, Collagen C orp. , Palo Al.tO, 
CAl six-wel l tissue-culture plates and grown (37°C , 5% CO2 ) in keratit]o-
cyte serum-free medium (Gibco BRL), supplemented with bovine pitui tary 
extract (50 J.Lg/ml) , epidermal growth fa ctor (5 ng/ml) , penicillin (:1.00 
V/m l) , streptom ycin (100 J.Lg/ml) , and L-glutamine (2 mM , Gibco BRL). 
Enzyme-Linked Imml1no Cell Adhesion Assay (ELICAA) As pn-, ,,i-
o usly desc ribed [1 4] m onolayers of keratinocytes (SVK 14) were grown 
un til confluency in 96-we ll microtiter pl<ltes. T lymphocytes were incubated 
w ith vario us mediators dllling 30 min at room temperature . Befure 
incubation with the T ce lls the kc r<ltinocyte monolaye rs were checked <tl1d 
each time fo ulld to be cOllfluent. T he keratinocyte monolayers were wasb e d 
once with kera tinocytc cul ture medium prior to the adhesion assay. After 
co-incuba tio n for 60 mill at 3?DC the nOli-adherent T cells were removed 
fro m the wells by washing. T he adherent T cell s were fixed usin g 
g lu tara ldehyde and incubated for 30 min with a monoclollal an tib~dy 
directed aga inst the leukocyte common antigen , w hich was labeled Weith 
horseradish pe roxidase. Ten minu tes after adding the substrate solu tion, 'th e 
reaction was stopped and the extinction va lues were measured at 492 IIn:t ill 
a Microp late au to reader (Biotek Instruments Inc.) [1 4] . O n each pt" te 
negative (unstimulated keratinocytes without T cell s, unstimulatcd ker"ti-
1I0cytes w ith unstimulated T cell s) and pos itive (PMA-stimulated T Cells 
with IFN-y treated keratinocytes) controls were included. T he extinct:jon 
va lue measured w hen ke ratinocytes were incubated without T cell s w as 
subtracted fi'om each me<ls ll red extillction va lue as b<l ckground. 1:"he 
extinction va lue of the pos itive cont.rol, w hich represented the maxi\"a l 
binding measured on ea ch plate. was arbi traril y set at 1 00%. To be ablQ to 
compare the extinction va lues between each pla te the adhesion \?Iras 
calcu la ted as the percentage of the max imum billding (PMA-stimula te<;:l T 
ce lls/ lFN-y--treated keratilloc)' tes, witho ut PTX) , which was set at 100% 
ad hesion. Each experiment was performed three times with T cell s fro m 
three different donors. 
T hree sets of experiments were perfo rmed : 
1. T ce ll s were left unstimulated , or they were sti ll1ulated during 30 1)1 in 
with PMA (0.'1, 0.5 , and 5 ng/ml) , or PMA and PTX (1 O- S_l 0- 2 M). 1:"h e 
complete T -cell incubation medium was added to the IFN-y-- or TN F~CI'­
treated keratinocyte mOllolayers (2 X lOs T cells pe r well), without 
washing , because washing of PM A-treated T ce ll s resulted ill clump ing c.fT 
cell s, as a resul t of wh.i ch the), could not be used ill the adhesion assay, 
2. Kcratinoc),te mono layers were left un treated, o r they were incub'ltcd 
during 48 h with IFN-y or TNF-a, or they were incuba ted witl, a 
combination o f PTX (10 - J M) and IFN-y, or PTX alld TNF-~. Afte r 
washing of the ke ratinocyte mOllo la yers, PMA-stimu lated T ce ll s "'ere 
added . 
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Table I. Measured Extinction Values of One of the 
Experitnents Shown and Described in Fig 1 n 
Extinction 
Type of Cells in Plate Value ::':: SO %, Adhesion 
Keratinocytes wi thout T cell s 0.032 ::':: 0.001 0% 
Keratinocytcs - IT cell s- 0.033 ::':: 0.013" 4 ::':: 2% 
Keratinocytes + IFN-y/ T 
cell s + PMA 0.820 ::':: 0.019b Set at 100% 
Keratillocytes + IFN-y/T cell s 
+ PMA + PTX 10- 2 M 0.147 ::':: 0.032" 18 ::':: 4% 
Keratinocytes + IFN-y/T cells 
+ PMA + PTX 10- 3 M 0.1 72 ::':: 0.024/' 21 ::':: 3% 
Keratinocytes + IFN-y / T cell s 
+ PMA + PTX 10- " M 0.295 ::':: 0 .016" 36 ::':: 2% 
Keratinocytes + IFN-y/T cell s 
+ PMA + PTX lO - s M 0.312 ::':: 0 .032" 38 ::':: 4%, 
" T cells were stimulated with PMA 0.5 ng/ ml. 
h Background extinction (0.032) wa~ already subtra cted from the extinction values 
Illcasurcd. 
3. T cells were treated d uring 30 min with PMA (0.5 ng/ml), PMA a.nd 
PTX (10- 3 M) , PMA and ffiMX (:10- 3 M) , or PMA and cAMP ana logues 
(10 - 3 M) and, without washing, co-incubated with IFN-y--treated kerati-
nocyte monolayers. 
Immunocytochemical Detection of Kcratinocytc ICAM- l Expres-
sion Monolayers of normal human keratinocytes were incubated with 
TNF-~ or IFN-y in the presence o r absence ofPTX (up to a concentration 
of10 - 3 M) during 48 h. ICAM-1 expression was detected using an indirect 
immunoperoxidase technique as described previously [15] and was assessed 
by light microscopy. 
Short-Term Organ Culture Normal human skin biopsies (2 mm2) 
were cultured by complete immersion in a culture medium consisting of 
OMEM, 10% feta l bovine serum, penicillin (100 U / m l) , and streptomycin 
(100 fLg / ml) .for" maximum duration of 72 h [1 6]. The addition oflFN-I'. 
TNF-a, or LPS (48 h) induced keratinocyte ICAM-1 expression. PTX 
(10 - 3 M) was added to the culture medium at the Same time as lFN-y, 
T N F-a, o r LPS. After incubation th e skin bio psies were snap- frozen in 
Liquid nitrogen and cryostat sections were examined for keratin ocyte 
ICAM-1 express ion using an indirect immunoperoxidase technique [1 5]. 
R ESULTS 
PTX Inhibits T -CeWKeratinocyte Adhesion (ELICAA) 
Whereas th e binding of n ative T cells to lmstil11ulate d k eratinocytes 
was minimal , T cells in cubated with PMA sh owed a stron g 
adh esion to IFN-y-- or T NF-a -stimulate d keratinocytes (Table I) . 
In preliminary experime nts PTX had b een added to the T cells a) 
togeth e r with PMA 30 min before the adh e sion assay, b) 15 min 
b e fore or after th e additio n of PMA (15 or 45 min before th e 
adhesion assay, respectively) , o r c) direc tl y b e fore addition of the T 
c e ll s to th e k e ratinocyte m o n o layer. As no diffe re n ces w er e found 
between th ese experime ntal approaches in furth e r e:\:p e rime nts 
PMA and PTX w e re added simultaneou sly 30 min prior to the 
adhesion assay. T h e T-cell suspension was added to th e keratino-
cyte mono layer w itho ut washing; thus, both PMA and PTX were 
present during the adhesio n assay. W h e n th e T cells were inc ubate d 
w i th both PMA and PTX in vario u s con centra tions, a dose-
depe n d e nt inhibition of tile T -cell / k e ratinocyte adhesion b y PTX 
was found . T h e con centration of PTX n eeded to inhibit til e 
T-ceU/ k e ratinocyte adh e sion d e p ende d on th e PMA con centration 
used to ac tivate th e T cells. W h e n low con centrations of PM A (0.1 
o r 0.5 n g/ml) w e re u sed , PTX inhibite d T - cell adherence for 
60-70'% at a con centration ofl0- 5 M, to 85% at a con centra tio n of 
10 - 2 M (Fig 1 and Table I). At a PMA con cen tration of 5 n g/ml , 
only a hig h con centra tion of PTX (10 - 2 M) resulte d in a consid-
erable inhibition (75% ) (Fig 1). 
In an oth e r set of exp e l;me nts th e e ffec t of keratinocyte pretreat-
m e nt w ith PTX on the T - cell / keratinocyte binding was investi-
gated . PTX (in con centrations up to 10 - 3 M) w as added to t h e 
keratinocyte c ultures toge the r with T NF-(X or IFN-y during 48 h . 
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Figure 1. PTX dose-dependently inhibits T-cell adherence to ke-
ratinocytes. Keratinocyte monolayers were incubated with IFN--y for 48 h 
and washed once with keratinocyte culture medium prior to the adhesion 
assay. T cells were incubated with varying concentrations of PMA (~, 5 
ng/ml;., 0.5 ng/ml;~, 0.1 ng/ml) and PTX (10- 5_10- 2 M. added at the 
same time as PMA) during 30 min prior to the ELICAA. The T-cell 
suspension was added to the keratinocyte monolayer without washing and 
incubated for 60 min at 37°C. T he non-adherent T cells were removed by 
washing. The anlount of adherent T ce lls was quantified as described in 
Materials mId Methods. The adhesion in the presence of PTX is expressed as 
the percentage relative to the adhesion of PMA-treated T cells in the 
absence of PTX (arbitrarily set at 100%). The means (n = 3) and standard 
deviations are given of a representative experiment. 
Prior to the adhesion assay the kerarinocyte monolayers were 
washed to remove PTX, and the keratinocytes were co-incubated 
with PMA-stimulated T cells for 1 h . Pretreatment ofkerarinocytes 
with PTX and TNF-a resulted at most in a slight, statistically not 
significant, reduction (0-25%) ofT-cell/keratinocyte binding. Pre-
treatment of keratinocytes with PTX and IFN--y did not result in 
inhibition of T -cell/kerarinocyte binding. 
PTX (10 - 5 to 10 - 2 M) was not cytotoxic for T cells, because the 
viabili ty of the T cell s after incubation with PTX, as determined 
with the trypan blue exclusion test, was always g reater than 98%. 
This is further supported by the observation that T cel.ls that had 
been incubated with PTX showed, after extensive washing (to 
remove PTX) and subsequent stimulation with PMA, an equally 
strong adh esion as PM A-treated T cells that were not pre-treated 
with PTX. Also the keratinocyte viability was not affected by PTX 
in concentrations up to 10 - 3 M (trypan blue exclusion test). 
However, higher concentrations of PTX (2.5 X 10 - 3 to 10- 2 M) 
inhibited the keratinocyte proliferation in a dose-dependent m ;lI1-
ner (data not shown). 
Effects ofmMX and cAMP Analogues on T-CelllKeratino-
cyte Binding When T cells were incubated during 30 min with 
PMA and IDMX (another methyLxanthine derivative) and co-
incubated, without washing, with IFN--y-treated kerarinocytes, the 
T-ceU/keratinocyte adhesion was inhibited for ::!:7S% (Fig 2) . 
Because PTX and lBMX increase intracellular cAMP levels and 
cAMP has been demonstrated to interfere with cell adhesion [17], 
the effect of cAMP analogues on T-cell/kerarinocyte binding was 
also studied. A combination of two cAMP analogues, when added 
to the T cells either t 5 min before or after or concurrently with 
PMA, had a simila r inhibitory effect on T-cell/kerati nocyte adhe-
sion as PTX. The results of a representative experiment, in which 
both cAMP analogues and PMA were added to the T cells, is 
presented ill Fig 2. 
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Figure 2. PTX, IDMX, and cAMP analognes inhibit T-cell adhe-
sion to keratinocytes. Keratinocyte monolayers were treated with IFN--y 
for 48 h prior to the ELICAA. T cells were incubated with PMA (0.5 
ng/ml), PMA and PTX (10- 3 M), PMA and IBMX (10 - 3 M), or PMA and 
cAMP analogucs (l0- 3 M) during 30 min prior to the ELlCAA. The T-cell 
suspension was added to the keratinocyte monolayer without washing, and 
co-incubated for 60 min at 37°C. The amount of adhering T cells was 
measured as described in Materials alld Met"ods. The ad/les ion in the presence 
of PM A and PTX, IBMX, or cA MP analogues is expressed as a perccntage 
relative to the adhesion of PMA-treated T cells without PTX, IBMX. or 
cAMP analogues (arbitrarily set at 100%). T he means (n = 3) and standard 
dev iations arc given of a representative experiment. 
Effect ofPTX on Keratinocyte ICAM-1 Expression 
MOllolayers: Incubation of normal human keratinocyte monolayers 
with TNF-a or IFN--y for 48 h resulted in a moderately strong 
ICAM-1 expression . When at the same time as the cytok.ines PTX 
(in concentrations up to 10 - 3 M) was added to the keratinocyte 
c u ltures, no inhibition of the ICAM-1 expression was found . PTX 
itself did not induce ICAM-1 expression, either in the monolayers 
or in the short-term organ culture . 
ShO/t- Term Organ G ,llt llre: Incubation of 110rmal human skin biop-
sies with TNF-a, LPS, or IFN--y for 48 h resulted in a strong and 
uniform epidermal staining for ICAM-l. Previous studies suggested 
that LPS induces kerarinocyte ICAM-1 expression indirectly via 
TNF-a production by dermal dendritic cells [15]. When PTX 
(10 - 3 M) was added to the culture medium at the same time as the 
cytokines, a complete il'lhibition of LPS- and TNF-a-induced 
keratinocyte ICAM-l expression was found. However, PTX had 
no effect on the IFN--y-induced keratinocyte ICAM-l expression 
(data not shown) . 
DISCUSSION 
In the present study it was demonstrated that PTX can cause a 
dose-dependent inhibition of PMA-activated T-cell adherence to 
IFN-y- or TNF-a-stimulated keratiJlocytes. The concentration of 
PTX needed to inhibit T-cell/keratinocyte binding strongly de-
pended on the concentration of PMA used to activate the T cells. 
When T cells were stim ulated with 0.1 or 0.5 ng/ml PMA, even a 
concentration of 10- 5 M PTX resulted in 60-70% illhibition. 
lBMX, another methylxanthine derivative, and cAMP analogues 
also inhibited the T -cell/keratinocyte binding. The mechanism 
underlying the il'lhibitiJlg effect of PTX on T-ceLl/keratinocyte 
bindmg is unknown . T-cell/keratinocyte binding is m ediated by 
the interaction between the adhesion molecules LFA-1 on T cells 
and ICAM-1 on keratiJlocy~es. Interference with expression or 
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availability of these adhesion molecules might be a possible expla-
nation for the eHect of PTX. 
Using fluorescence-activated cell sorter analysis no differen ces 
were found in the percentage of LFA-1 expressing T cells (always 
greater than 98%), o r in the intensity of the LFA-1 staining between 
native T cells, PMA-activated T cells and T cells incubated with 
PMA and PTX. Previous studies by others have also suggested that 
LFA-I/ICAM-l-dependent adherence is not caused by 3n in-
creased expression of LFA-1, but is associated w ith a redistribution 
ofLFA-l at the cell surface [1 8]. In unactivated T cells, LFA-l has 
a uniform distribution on the cell surface. PMA treatment leads to 
activa tion of prote in kinase C (PKC) , which in turn causes con-
densation of cytoskeletal elem ents resulting in capping of LFA-l, 
which precedes increased T-cell adherence [18]. R ecent studies 
have demonstrated that an elevation of cAMP can effectively block 
the PKC-induced cytoskeleton condensation and LFA-l redistribu-
tion (capping), and in this way blocks the conjugation between 
cytolytic T cells and target cells [1 9], as well as LFA-1/TCAM-l-
m ediated aggregation of JY cell s [1 7]. PTX is a well-known 
phosphodiesterase inhibitor. Inhibition of this enzyme, which deg-
radates cAMP to 5' -AMP, results in increased levels of intracellular 
cA MP [20]. Taken together, these data suggest that inhibition of 
the binding by PTX is m ediated via an increase in the level of 
cAMP and its eHect on the redistribution of the LFA-l molecule. 
Our observation that incubation of T cells with cAMP analogues 
also resulted in a decreased adherence to keratinocytes provides 
furth er support for this view. 
T he observation that PTX inhibits T-cell/keratinocyte adhesion 
inespective of the addition of PTX before, after or at the same time as 
PMA to the T cells suggests that PTX is capable of bo th preventing 
and reversing the PMA-induced adhesion. It should be emphasized 
tha t inhibition of T -cell / keratinocyte binding could only be demon-
strated when PTX was present during the adhesion assay. As men-
tioned before, washing of the PM A-activated T cells to remove PTX 
was not possible because of the resulting clumping of the T cells, 
which could not be used in the adhesion assay anymore. Therefore, the 
possibility that PTX also influences the keratinocytes du.ring the 
adhesion assay cannot completely be excluded. However, the addition 
ofPTX, together with IFN-y or TNF-Cl', to the keratinocytes did not 
result in in!libition of T -cell/ keratinocyte binding. T llis is in line with 
the finding that in keratinocyte monolayers incubated with a combi-
nation of TNF-Cl' or IFN-y and PTX, no inhibition of keratinocyte 
ICAM-1 expression was fOl\J1d . In contrast, the results of our short-
tenn organ-culture studies showed that PTX can completely inllibit 
T NF-Cl'- and LPS-, but not TFN-y--induced keratinocyte ICAM-1 
expression . T llis discrepancy between the results obtained in short-
term organ culture and keratinocyte monolayer experiments has also 
been described by De Fraisinette et at [21] , and is as yet 11l1e"'"Plained. 
[n conclusion, the observation that PTX can interfere with the 
T - cell /keratinocyte adh erence, and can also inllibit the production 
of macrophage [8] and keratinocyte-derived cytokines such as 
TNF-Cl', IL-1 , and IL-6,'I' suggests that PTX may be a useful agent 
'I' Schwarz A, Aragonc Y , Simon M , Luger TA, Schwarz T: Pcntoxi fy l-
line (PTX) suppresses UVB-induced cytokine release by kcratinocytes 
(abstr).J /tllJes / Demln/ollOl:388, 1993. 
-
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in inflammatory skin diseases in which T-cell/keratinocyte binding 
plays an important role. 
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